• Login
    • Join
  • FOLLOW:
  • Subscribe Free
    • Magazine
    • eNewsletter
    Checkout
    • Magazine
    • News
    • Opinions
    • Top 30
    • Research
    • Supply Chain
    • Device Sectors
    • Directory
    • Events
    • Resources
    • Microsites
    • More
  • Magazine
  • News
  • Opinions
  • Top 30
  • Research
  • Supply Chain
  • Device Sectors
  • Directory
  • Events
  • Resources
  • Microsites
  • Current / Back Issues
    Features
    Editorial
    Digital Edition
    eNewsletter Archive
    Our Team
    Editorial Guidelines
    Reprints
    Subscribe Now
    Advertise Now
    Top Features
    Pharmaceutical Focus: A Look at Combination Products

    The Printed World: Additive Manufacturing in Medtech

    The Lost Year: 2020 Year in Review

    Extrusion Evolution

    Little Big Parts: Micromolding Under the Microscope
    OEM News
    Supplier News
    Service / Press Releases
    Online Exclusives
    Press Releases
    People in the News
    Product & Service Releases
    Supplier News
    Medtech Makers
    Technical Features
    International News
    Videos
    Product & Service Releases
    Live From Shows
    Top News
    Alleviant's Transcatheter Tech Obtains Breakthrough Status

    Signia Appoints New President

    At-Home COVID-19 Test Kits Boosts Disease Monitoring Capabilities

    QT Imaging Signs Distribution Agreement With Freedom Ventures for Breast Scanner

    MedAcuity, Fathom Partner on Human Factors Engineering Services
    From the Editor
    Blogs
    Guest Opinions
    Top Opinions
    Pharmaceutical Focus: A Look at Combination Products

    The Printed World: Additive Manufacturing in Medtech

    The Lost Year: 2020 Year in Review

    Extrusion Evolution

    Little Big Parts: Micromolding Under the Microscope
    Top 30 Medical Device Companies
    Market Data
    White Papers
    Top Research
    Fixing Face Mask Form and Function

    The Heart of the Matter: Trends in Cardiology

    Virtually the Same? The Challenges of Online Conferences

    Digital Health Delivers During a Year for the Ages

    Advanced Technology for Staking and Swaging Medical Plastics
    3D/Additive Manufacturing
    Contract Manufacturing
    Electronics
    Machining & Laser Processing
    Materials
    Molding
    Packaging & Sterilization
    R&D & Design
    Software & IT
    Testing
    Tubing & Extrusion
    Cardiovascular
    Diagnostics
    Digital Health
    Neurological
    Patient Monitoring
    Surgical
    Orthopedics
    All Companies
    Categories
    Company Capabilities
    Add New Company
    Outsourcing Directory
    Concise Engineering

    MW Life Sciences

    Medicoil

    Unicep

    FUTEK Advanced Sensor Technology Inc.
    MPO Summit
    Industry Events
    Webinars
    Live From Show Event
    Industry Associations
    Videos
    Career Central
    eBook
    Slideshows
    Top Resources
    Meeting Critical Ventilator Product Requirements Amid Pandemic

    Impact of COVID-19 on the Medtech Supply Chain

    Finding the Upside to a Challenging Year

    Preparing Your Design Controls for FDA Approval

    A 'Trial and Error' Approach to Micromolded Parts
    Companies
    News Releases
    Product Releases
    Press Releases
    Product Spec Sheets
    Service Releases
    Case Studies
    White Papers
    Brochures
    Videos
    Outsourcing Directory
    Medicoil

    Qosina Corp.

    Concise Engineering

    K-Tube Technologies

    Element
    • Magazine
      • Current/Back Issues
      • Features
      • Editorial
      • Columns
      • Digital Editions
      • Subscribe Now
      • Advertise Now
    • News
    • Directory
      • All Companies
      • ALL CATEGORIES
      • Industry Associations
      • Company Capabilities
      • Add Your Company
    • Supply Chain
      • 3D/Additive Manufacturing
      • Contract Manufacturing
      • Electronics
      • Machining & Laser Processing
      • Materials
      • Molding
      • Packaging & Sterilization
      • R&D & Design
      • Software & IT
      • Testing
      • Tubing & Extrusion
    • Device Sectors
      • Cardiovascular
      • Diagnostics
      • Digital Health
      • Neurological
      • Patient Monitoring
      • Surgical
      • Orthopedics
    • Top 30 Company Report
    • Expert Insights
    • Slideshows
    • Videos
    • Podcasts
    • Resources
    • eBook
    • Infographics
    • Whitepapers
    • Research
      • White Papers
      • Case Studies
      • Product Spec Sheets
      • Market Data
    • MPO Summit
    • Events
      • Industry Events
      • Live From Show Events
      • Webinars
    • Microsite
      • Companies
      • Product Releases
      • Product Spec Sheets
      • Services
      • White Papers / Tech Papers
      • Press Releases
      • Videos
      • Literature / Brochures
      • Case Studies
    • About Us
      • About Us
      • Contact Us
      • Advertise with Us
      • eNewsletter Archive
      • Privacy Policy
      • Terms of Use
    Breaking News

    Remote Control Fires Laser at Nano-Gold to Activate Cancer-Killing Immune Cells

    Heat-sensitive switch installed into T-cells can activate the T-cells when heat turns the switch on.

    Remote Control Fires Laser at Nano-Gold to Activate Cancer-Killing Immune Cells
    Gentle pulses from a near-infrared laser hit gold nanorods, which warm up T-cells in in vitro tests, successfully activating a genetic switch implanted in the T-cells. Subsequent tests in vivo in mice with implanted phantom tumors confirmed massive gene expression triggered by the switch. Future experiments will be aimed at confirming cancer-fighting effectiveness. All images courtesy of Georgia Tech/Allison Carter.
    Related CONTENT
    • Infus Medical (Thailand) Co. Ltd.
    • Diagnostic May Bring Faster, Cheaper Cancer Testing to Remote Settings
    • Application Detects Cancer Cells in Abdominal Cavity in Real Time
    • New AI 'Smart Pill' Images Gut to Spot Cancer
    • Blood Test May Help Doctors Catch Pancreatic Cancer Early
    Georgia Institute of Technology04.20.18
    A remote command could one day send immune cells on a rampage against a malignant tumor. The ability to mobilize, from outside the body, targeted cancer immunotherapy inside the body has taken a step closer to becoming reality.
     
    Bioengineers at the Georgia Institute of Technology have installed a heat-sensitive switch into T-cells that can activate the T-cells when heat turns the switch on. The method, tested in mice and published in a new study, is locally targeted and could someday help turn immunotherapy into a precision instrument in the fight against cancer.
     
    Immunotherapy has made headlines with startling high-profile successes like saving former U.S. President Jimmy Carter from brain cancer. But the treatment, which activates the body's own immune system against cancer and other diseases, has also, unfortunately, proved to be hit-or-miss.
     
    "In patients where radiation and traditional chemotherapies have failed, this is where T-cell therapies have shined, but the therapy is still new," said principal investigator Gabe Kwong. "This study is a step toward making it even more effective."
     
    Laser, Gold, and T-cells
    In the study, Kwong's team successfully put their remote-control method through initial tests in mice with implanted tumors (so-called tumor phantoms, specially designed for certain experiments). The remote works via three basic components.
     
    First, the researchers modified T-cells, a type of white blood cell, to include a genetic switch that, when switched on, increased the cells' expression of specific proteins by more than 200 times. That ability could be used to guide T-cells' cancer-fighting activities.
     
    The T-cells, with the switch off, were introduced into the tumor phantom which was placed into the mice. The tumor phantom also included gold nanorods, just dozens of atoms in size. The researchers shone pulses of a gentle laser in the near-infrared (NIR) range from outside the mouse's body onto the spot where the tumor was located.
     
    The nanorods receiving the light waves turned them into useful, localized mild heat, allowing the researchers to precisely warm the tumor. The elevated heat turned on the T-cells' engineered switch.
     
    Hyper-Activated T-cells
    This study honed the method and confirmed that its components worked in living animals. It was not the intention of the study to treat cancer yet, although undertaking that is the next step, which is already on its way.
     
    "In upcoming experiments, we are implementing this approach to treat aggressive tumors and establish cancer-fighting effectiveness," said Kwong, who is an assistant professor in the Wallace H. Coulter Department of Biomedical Engineering at Georgia Tech and Emory University.
     
    The researchers published their results in the current edition of the journal ACS Synthetic Biology. The study's first author was graduate research assistant Ian Miller. The research was funded by the National Institutes of Health, the National Science Foundation, the Burroughs Wellcome Fund, and the Shurl and Kay Curci Foundation.
     
    Better Immunotherapy
    Bioengineers have been able to do a lot with T-cells already when they're outside of the body.
     
    "Right now, we're adept at harvesting a patient's own T-cells, modifying to target cancer, growing them outside the body until there are hundreds of millions of them," Kwong said. "But as soon as we inject them back into a patient, we lose control over the T-cells' activity inside the body."
     
    Cancer is notoriously wily, and when T-cells crawl into a tumor, the tumor tends to switch off the T-cells' cancer-killing abilities. Researchers have been working to switch them back on.
    Kwong's remote control has done this in the lab, while also boosting T-cell activity.
     
    T-cell Toxicities
    Having an off-switch is also important. If T-cells were engineered to be always-on and hyper-activated, as they moved through the body, they could damage healthy tissue.
     
    "There would be off-target toxicities, so you really want to pinpoint their activation," Kwong said. "Our long-term goal for them is to activate site-specifically, so T-cells can overcome immunosuppression by the tumor and become better killers there."
     
    When the heat remote is turned off, so are Kwong's engineered T-cells, because customary body temperatures are not high enough to activate their switch.
     
    Heat-Shock Switch
    The switch is a natural safety mechanism in human cells that has evolved to protect against heat shock and turns on when tissue temperatures rise above the body's normal operating range, which centers on 37 degrees Celsius (98.6 F). But the researchers re-fitted T-cells with the switch to make it turn on other functions, and it could be used to hyper-activate the cells.
     
    The Georgia Tech bioengineers found that the switch worked in a range of 40 to 42 degrees Celsius (104 - 107.6 F), high enough to not react to the majority of high fevers and low enough to not damage healthy tissue nor the engineered T-cells.
     
    "When the local temperature is raised to 45 degrees (113 F), some cells in our body don't like it," Kwong said. "But if heating is precisely controlled in a 40 to 42 degrees window with short pulses of the NIR light, then it turns on the T-cells' switch, and body cells are still very comfortable."
     
    Immuno-Goals and Dreams
    The researchers want to combine the switch with some additional cancer-fighting weapons they envision engineering into T-cells.
     
    For example, secreted molecules called cytokines can boost immune cells' ability to kill cancer, but cytokines, unfortunately, can also be toxic. "Our long-term goal is to engineer T-cells to make and release powerful immune system stimulants like cytokines on command locally and sparingly," Kwong said.
     
    In other studies, gently heated gold nanorods have been shown to kill tumors or hinder metastasis. But T-cell treatments could be even more thorough and, in addition, hopefully, one day give patients treated with them a long-lasting memory immune response to any recurrence of their cancer.

    Find more information on the study here.
    Related Searches
    • health
    • engineering
    • it
    • national science foundation
    Suggested For You
    Infus Medical (Thailand) Co. Ltd. Infus Medical (Thailand) Co. Ltd.
    Diagnostic May Bring Faster, Cheaper Cancer Testing to Remote Settings Diagnostic May Bring Faster, Cheaper Cancer Testing to Remote Settings
    Application Detects Cancer Cells in Abdominal Cavity in Real Time Application Detects Cancer Cells in Abdominal Cavity in Real Time
    New AI New AI 'Smart Pill' Images Gut to Spot Cancer
    Blood Test May Help Doctors Catch Pancreatic Cancer Early Blood Test May Help Doctors Catch Pancreatic Cancer Early
    FDA Grants Lucid Diagnostics Breakthrough Device Designation for Esophageal DNA Test FDA Grants Lucid Diagnostics Breakthrough Device Designation for Esophageal DNA Test
    Clinical Trial Tests Clinical Trial Tests 'Tattoo Sensor' as Needleless Glucose Monitor
    Wisdom Tooth: Electronic Sensor Checks Saliva to Screen for Disease Wisdom Tooth: Electronic Sensor Checks Saliva to Screen for Disease
    FDA Finalizes Guidances to Speed Development of Next-Generation Sequencing Based Tests FDA Finalizes Guidances to Speed Development of Next-Generation Sequencing Based Tests
    Augmenix Opens New U.K. Regional Headquarters              Augmenix Opens New U.K. Regional Headquarters
    New Blood Test Can Help Identify People at Risk for Developing Alzheimer New Blood Test Can Help Identify People at Risk for Developing Alzheimer's
    Early Stimulation Improves Performance of Bioengineered Human Heart Cells Early Stimulation Improves Performance of Bioengineered Human Heart Cells
    Tiny Biochip Can Detect Disease Without Complex Lab Equipment Tiny Biochip Can Detect Disease Without Complex Lab Equipment
    Auris Health Unveils the FDA-Cleared Monarch Platform Auris Health Unveils the FDA-Cleared Monarch Platform
    Endomag’s Magseed Marker Receives FDA Clearance for Long-Term and Soft Tissue Implantation Endomag’s Magseed Marker Receives FDA Clearance for Long-Term and Soft Tissue Implantation

    Related Breaking News

    • Cardiovascular
      Alleviant

      Alleviant's Transcatheter Tech Obtains Breakthrough Status

      The technology offers a no-implant interatrial shunt therapy for heart failure patients.
      Sam Brusco, Associate Editor 01.25.21

    • Signia Appoints New President

      Signia Appoints New President

      New executive most recently worked for Essilor of America.
      Michael Barbella 01.25.21

    • At-Home COVID-19 Test Kits Boosts Disease Monitoring Capabilities

      At-Home COVID-19 Test Kits Boosts Disease Monitoring Capabilities

      Public health officials need to stress the importance of mass testing and contact tracing even with several vaccines approved.
      Michael Barbella 01.25.21


    • QT Imaging Signs Distribution Agreement With Freedom Ventures for Breast Scanner

      QT Imaging Signs Distribution Agreement With Freedom Ventures for Breast Scanner

      Transmission ultrasound breast imaging now to become available in EMEA markets.
      Michael Barbella 01.25.21

    • MedAcuity, Fathom Partner on Human Factors Engineering Services

      MedAcuity, Fathom Partner on Human Factors Engineering Services

      Focused on facilitating safe and effective use of medical devices, HFE is a critical aspect of product development.
      Michael Barbella 01.25.21

    • Cretex Companies CEO Steps Down

      Cretex Companies CEO Steps Down

      Jeff Wollerman will succeed Lynn Schuler as CEO of the company.
      Charles Sternberg, Assistant Editor 01.22.21


    • Data Show Porex

      Data Show Porex's Medical Device Filtration Materials Protect Against Virus, Bacteria Spread

      Company initiates VFE testing for its porous polymer-based materials; results show components protect against certain aerosolized viruses.
      Michael Barbella 01.22.21

    • Endoscopic Hemostasis Devices Market Valued at $730 Million

      Endoscopic Hemostasis Devices Market Valued at $730 Million

      Value has driven by the recent approval of new devices.
      Michael Barbella 01.22.21

    • Henry Schein Buys Majority Interest in Prism Medical Products

      Henry Schein Buys Majority Interest in Prism Medical Products

      PRISM will operate as a subsidiary of Henry Schein Medical and will be managed separately as an individual division.
      Michael Barbella 01.22.21


    • Neurological
      Boston Scientific

      Boston Scientific's Vercise Genus DBS Earns FDA Approval

      Fourth-generation DBS portfolio features full-body MR conditional devices.
      Sam Brusco, Associate Editor 01.22.21

    • Biotech Team Develops ELISA Protocol for COVID-19 Antibody Detection

      Biotech Team Develops ELISA Protocol for COVID-19 Antibody Detection

      The new detection method can help determine whether patients have had COVID-19 and if they might still have immunity to the disease.
      Michael Barbella 01.22.21

    • TPI Partners with Zeiss

      TPI Partners with Zeiss

      Enables TPI to deliver 3D X-Ray Measurement capabilities for Quality Assurance for its clients.
      Charles Sternberg, Assistant Editor 01.21.21


    • Tubing & Extrusion
      PPE Moves into New Manufacturing Facility

      PPE Moves into New Manufacturing Facility

      New building is twice the size of the old one.
      Charles Sternberg, Assistant Editor 01.21.21

    • Neurent Medical Closes $25 Million Series B Financing

      Neurent Medical Closes $25 Million Series B Financing

      Supports the expansion of the company’s clinical and commercial operations.
      Charles Sternberg, Assistant Editor 01.21.21

    • Alcon Releases PRECISION1 for Astigmatism Contact Lenses in U.S.

      Alcon Releases PRECISION1 for Astigmatism Contact Lenses in U.S.

      The daily disposable, silicone hydrogel contact lens for astigmatism will roll out concurrently worldwide beginning in February.
      Sam Brusco, Associate Editor 01.21.21


    Trending
    • Portable, Home-Use Device Quickly Measures Inflammation Levels
    • Masimo Earns CE Mark For New Fingertip Pulse Oximeter
    • Cytotron Gains Breakthrough Status To Treat Breast, Liver, And Pancreatic Cancers
    • At-Home COVID-19 Test Kits Boosts Disease Monitoring Capabilities
    • Top 10 Trends In The Medical Device And Equipment Industry
    Breaking News
    • Alleviant's Transcatheter Tech Obtains Breakthrough Status
    • Signia Appoints New President
    • At-Home COVID-19 Test Kits Boosts Disease Monitoring Capabilities
    • QT Imaging Signs Distribution Agreement With Freedom Ventures for Breast Scanner
    • MedAcuity, Fathom Partner on Human Factors Engineering Services
    View Breaking News >
    CURRENT ISSUE

    November/December 2020

    • Pharmaceutical Focus: A Look at Combination Products
    • The Printed World: Additive Manufacturing in Medtech
    • The Lost Year: 2020 Year in Review
    • View More >

    Cookies help us to provide you with an excellent service. By using our website, you declare yourself in agreement with our use of cookies.
    You can obtain detailed information about the use of cookies on our website by clicking on "More information”.

    • About Us
    • Privacy Policy
    • Terms And Conditions
    • Contact Us

    follow us

    Subscribe
    Nutraceuticals World

    Latest Breaking News From Nutraceuticals World

    Clinical Evidence Suggests Potential Oral Benefits for Curcumin Extract
    Oleic Acid Possibly Implicated in MS Pathology
    NIH Study Compares Low-Fat, Plant-Based to Low-Carb, Animal-Based Diet
    Coatings World

    Latest Breaking News From Coatings World

    APV Engineered Coatings Reflects on 2020
    LINE-X Launches Dealer Program with International Truck
    BCF CEO to Chair Royal Society of Chemistry Surface Coatings Interest Group
    Medical Product Outsourcing

    Latest Breaking News From Medical Product Outsourcing

    Alleviant's Transcatheter Tech Obtains Breakthrough Status
    Signia Appoints New President
    At-Home COVID-19 Test Kits Boosts Disease Monitoring Capabilities
    Contract Pharma

    Latest Breaking News From Contract Pharma

    Civica to Build an Essential Medicines Manufacturing Facility in Virginia
    Humanigen, Emergent Enter Covid-19 Partnership
    Samsung Bioepis Opens New Headquarters
    Beauty Packaging

    Latest Breaking News From Beauty Packaging

    Fitglow Beauty Wins Big at Annual Dirty Thinker’s Choice Awards
    e.l.f. Cosmetics Unveils Mint Melt Collection
    Estée Lauder Companies Updates Supply Chain Leadership
    Happi

    Latest Breaking News From Happi

    Wellness Brand Found Active Partners with Kate Upton
    New Research Supports the Efficacy of Sabinsa’s Curcumin C3 Reduct
    Curcumin's Role in Oral Care
    Ink World

    Latest Breaking News From Ink World

    Paragon Expands Direct Mail Capabilities with Ricoh Pro VC70000
    BOBST Demonstrates Future of Flexible Packaging Production at Virtual Open House
    Morancé Soudure France Adds Comexi F2 MC 10-color Flexo Press
    Label & Narrow Web

    Latest Breaking News From Label & Narrow Web

    VPF launches deep-freeze adhesive
    ProMach strengthens flexible packaging business
    Gallus planning virtual event for March
    Nonwovens Industry

    Latest Breaking News From Nonwovens Industry

    Kimberly-Clark Releases Q4, Full Year Results
    Freudenberg to Establish Apparel Interlining Competence Centers
    Minet Adds Spunlace Line in Romania
    Orthopedic Design & Technology

    Latest Breaking News From Orthopedic Design & Technology

    First Patient Implanted With NEXXT MATRIXX SA Cervical Turn-Lock System
    Cretex Companies CEO Steps Down
    Conformis Enters Development & Supply Agreement with SITES Medical
    Printed Electronics Now

    Latest Breaking News From Printed Electronics Now

    First Solar Signs Definitive Agreement to Sell US Development Platform to Leeward
    Imec Technology Taking Off to Space
    Osram in Top 25 of World’s 100 Most Sustainable Companies

    Copyright © 2021 Rodman Media. All rights reserved. Use of this constitutes acceptance of our privacy policy The material on this site may not be reproduced, distributed, transmitted, or otherwise used, except with the prior written permission of Rodman Media.

    AD BLOCKER DETECTED

    Our website is made possible by displaying online advertisements to our visitors.
    Please consider supporting us by disabling your ad blocker.


    FREE SUBSCRIPTION Already a subscriber? Login